Risk factors include receiving intubation, a central venous line, or a drain, plus receipt of antifungal drugs within 7 days of admission.
Analysis of wastewater isolates revealed phylogenetic relatedness to isolates from three acute-care hospitals in the same watershed.
Despite limited data, new WHO report highlights 19 fungi that represent the greatest threat to public health.
The European Centre for Disease Prevention and Control (ECDC) yesterday issued a warning about an ongoing outbreak of the multidrug-resistant yeast Candida auris in Italy.
A randomized clinical trial found that fosfomycin did not demonstrate noninferiority to comparator antibiotics for bacteremic urinary tract infections (bUTIs) caused by multidrug-resistant (MDR) Escherichia coli, but it could remain an option for select patients, researchers reported yesterday in JAMA Network Open.
A team of Indian scientists yesterday reported the detection of Candida auris isolates from two sampling sites on islands in the Indian Ocean—the first time the multidrug-resistant yeast has been isolated in a natural environment. The discovery was reported in mBio.
The Democratic Republic of the Congo (DRC) yesterday announced a new Ebola case, its first since September, which involves a woman who died from her infection in Butembo, one of the main hot spots in the country's 10th outbreak that was centered in North Kivu and Ituri provinces.
Five barriers to better antibiotic decision-making at hospital discharge emerged after John Hopkins University School of Medicine researchers interviewed healthcare workers and discharged patients.
Two new studies highlight the threat posed by the multidrug-resistant yeast Candida auris to hospitalized COVID-19 patients.
In a study today in the Journal of the Pediatric Infectious Diseases Society, US and Colombian researchers report that nearly one-third of the pediatric invasive Candida bloodstream infections (BSIs) analyzed at two Colombian pediatric hospitals were caused by Candida auris.
